Modified Checklist for Autism in Toddlers in a Neonatal High-Risk Population

Benjamin Lassebro1,2, Matilda Morin3, Weiyao Yin3

  • 1Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.

JAMA Network Open
|March 27, 2026
PubMed

Insights

The Modified Checklist for Autism in Toddlers (M-CHAT) shows high specificity but moderate sensitivity for detecting autism spectrum disorder (ASD) in high-risk neonates. Additional tools are needed to improve early ASD detection in this population.

Area of Science:

  • Neurodevelopmental Disorders
  • Pediatric Health
  • Diagnostic Accuracy Studies

Background:

  • Autism spectrum disorder (ASD) is a complex neurodevelopmental condition with significant genetic and environmental influences.
  • Early detection and intervention are critical for improving outcomes in children with ASD.
  • Neonatal high-risk populations may benefit from targeted screening for early identification of developmental differences.

Purpose of the Study:

  • To evaluate the diagnostic accuracy of the Modified Checklist for Autism in Toddlers (M-CHAT) in a cohort of high-risk neonates.
  • To compare M-CHAT performance against established clinical diagnoses of ASD.
  • To identify factors influencing M-CHAT accuracy within this specific neonatal group.

Main Methods:

  • A prospective, population-based cohort study in Sweden included neonates born between 2013-2019.
  • Children underwent M-CHAT screening at 16-30 months corrected age.
  • ASD diagnoses were tracked via the National Patient Register until December 2022.

Main Results:

  • The study included 2178 high-risk neonates; 12.1% had positive M-CHAT screens.
  • Overall M-CHAT sensitivity was 62.4%, specificity 91.2%, positive predictive value 31.4%, and negative predictive value 97.4%.
  • Extremely preterm infants showed the highest rates of positive screens and ASD diagnoses.

Conclusions:

  • The M-CHAT demonstrates high specificity but only moderate sensitivity for ASD detection in high-risk neonates.
  • Current screening may miss a significant proportion of affected infants, necessitating complementary diagnostic approaches.
  • Further research is needed to enhance early ASD identification in vulnerable neonatal populations.
Abstract

Related Concept Videos